Subsidy programme for gestational diabetes mellitus screening and lifestyle management in rural areas of western China: a study protocol for a multicentre randomised controlled trial

被引:6
|
作者
Xu, Tingting [1 ,2 ]
Lai, Xiaozhen [2 ]
He, Kun [2 ]
Ma, Liangkun [3 ]
Fang, Hai [2 ,4 ]
机构
[1] Capital Med Univ, Sch Publich Hlth, Beijing, Peoples R China
[2] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China
[3] Peking Union Med Coll Hosp, O&G, Beijing, Peoples R China
[4] Peking Univ, China Ctr Hlth Dev Studies, Beijing, Peoples R China
来源
BMJ OPEN | 2021年 / 11卷 / 07期
关键词
diabetes in pregnancy; health economics; health policy; risk management; international health services; RISK-FACTORS; WOMEN; PREGNANCY; QUESTIONNAIRE; HYPERGLYCEMIA; ASSOCIATION; PREVENTION; OUTCOMES; QUALITY; GLUCOSE;
D O I
10.1136/bmjopen-2020-045503
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Gestational diabetes mellitus (GDM) has become an increasing health problem among pregnant women in western rural China. Insufficient compliance and motivation due to economic factors is one of the major contributors to the currently low GDM screening and management rate. A subsidy program offering GDM screening and lifestyle management might be an effective way to increase pregnant women's awareness of GDM, and further improve maternal and neonatal health in western rural China. This study had two primary purposes: (1) to examine whether the subsidy program would increase the screening and management rates of GDM and reduce adverse complications for mothers and new-born babies and (2) to evaluate whether the subsidy program is cost-effective from a societal perspective. Methods and analysis This randomised controlled trial will include 3000 pregnant women (at 24-28 weeks of pregnancy) who will be followed up at six hospitals in the provinces of Yunnan, Sichuan and Shaanxi in China. Pregnant women without overt diabetes, with a singleton pregnancy, with telephone access and with written informed consent will be invited. The intervention group will receive subsidies and standard care, and the control group will only receive usual antenatal care. The randomisation sequence will be stratified by study sites with balanced blocks of six patients. Data will be collected using self-report questionnaires and hospital records. Data will be analysed according to the intention-to-treat principle. The primary outcomes are the maternal and neonatal complications. Secondary outcomes are the mother's cognition scores, screening rate, number of re-examinations, weight gain during pregnancy, changes in diet and exercise, and quality of life. Group comparisons will be conducted using chi(2) test for categorical variables, and t-test or the Mann-Whitney-Wilcoxon test for continuous variables where applicable. Multiple logistic regression will also be performed for the primary outcomes. Ethics and dissemination This study was approved by the Ethics Review Committee of Peking University Health Science Center. Findings will be disseminated through publication in peer-reviewed journals, seminars and national and international conferences.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] DiAlert: a lifestyle education programme aimed at people with a positive family history of type 2 diabetes and overweight, study protocol of a randomised controlled trial
    Heideman, Wieke H.
    Nierkens, Vera
    Stronks, Karien
    Middelkoop, Barend J. C.
    Twisk, Jos W. R.
    Verhoeff, Arnoud P.
    de Wit, Maartje
    Snoek, Frank J.
    BMC PUBLIC HEALTH, 2011, 11
  • [22] Screening for gestational diabetes mellitus in primary versus secondary care: The clinical outcomes of a randomised controlled trial
    O'Dea, Angela
    Tierney, Marie
    Danyliv, Andriy
    Glynn, Liam G.
    McGuire, Brian E.
    Carmody, Louise A.
    Newell, John
    Dunne, Fidelma P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 117 : 55 - 63
  • [23] Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: study protocol for an international, prospective, multicentre cohort trial
    Huhn, E. A.
    Fischer, T.
    Goebl, C. S.
    Bernasconi, M. Todesco
    Kreft, M.
    Kunze, M.
    Schoetzau, A.
    Doelzlmueller, E.
    Eppel, W.
    Husslein, P.
    Ochsenbein-Koelble, N.
    Zimmermann, R.
    Baez, E.
    Proempeler, H.
    Bruder, E.
    Hahn, S.
    Hoesli, I.
    BMJ OPEN, 2016, 6 (10):
  • [24] Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL) A Randomized Controlled Trial
    Koivusalo, Saila B.
    Rono, Kristiina
    Klemetti, Miira M.
    Roine, Risto P.
    Lindstrom, Jaana
    Erkkola, Maijaliisa
    Kaaja, Risto J.
    Poyhonen-Alho, Maritta
    Tiitinen, Aila
    Huvinen, Emilia
    Andersson, Sture
    Laivuori, Hannele
    Valkama, Anita
    Meinila, Jelena
    Kautiainen, Hannu
    Eriksson, Johan G.
    Stach-Lempinen, Beata
    DIABETES CARE, 2016, 39 (01) : 24 - 30
  • [25] Lifestyle Intervention in Chronic Ischaemic Heart Disease and Type 2 Diabetes (the LeIKD study): study protocol of a prospective, multicentre, randomised, controlled trial
    von Korn, Pia
    Sydow, Hanna
    Neubauer, Sarah
    Duvinage, Andre
    Mocek, Anja
    Dinges, Sophia
    Hackenberg, Bjoern
    Weichenberger, Mario
    Schoenfeld, Julia
    Amelung, Volker
    Mueller, Stephan
    Halle, Martin
    BMJ OPEN, 2021, 11 (02):
  • [26] The PULSE (Prevention Using LifeStyle Education) trial protocol: a randomised controlled trial of a Type 2 Diabetes Prevention programme for men
    Aguiar, Elroy J.
    Morgan, Philip J.
    Collins, Clare E.
    Plotnikoff, Ronald C.
    Young, Myles D.
    Callister, Robin
    CONTEMPORARY CLINICAL TRIALS, 2014, 39 (01) : 132 - 144
  • [27] Digital therapeutics-based lifestyle intervention for gestational diabetes mellitus prevention of high-risk pregnant women: a study protocol for a non-randomised controlled trial
    Lin, Lihua
    Dong, Jiayi
    Wang, Youxin
    Song, Libin
    Ye, Xiaoyan
    Chen, Xingying
    Miao, Chong
    Lin, Juan
    BMJ OPEN, 2024, 14 (06):
  • [28] Impact of an SMS advice programme on maternal and newborn health in rural China: study protocol for a quasi-randomised controlled trial
    Su, Yanfang
    Yuan, Changzheng
    Zhou, Zhongliang
    Heitner, Jesse
    Campbell, Benjamin
    BMJ OPEN, 2016, 6 (08):
  • [29] A pragmatic lifestyle intervention for overweight and obese women with gestational diabetes mellitus (PAIGE2): A parallel arm, multicenter randomized controlled trial study protocol
    McAuley, Emma
    Fleck, Olwen
    Cassidy, Laura
    Kemp, Bridie J.
    Cupples, Gina
    Kelly, Bronagh
    Creighton, Rachel M.
    Graham, Una
    Wallace, Helen
    Patterson, Chris C.
    McCance, David R.
    FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2023, 4
  • [30] Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial
    Ibrahim, Ibrahim
    Abdullahi, Hala
    Fagier, Yassin
    Ortashi, Osman
    Terrangera, Annalisa
    Okunoye, Gbemisola
    BMJ OPEN, 2022, 12 (01):